Boston Research Management Inc Lowers stake in Laboratory Corp. of America Holdings (LH)

Laboratory Corp. of America Holdings (LH) : Boston Research Management Inc reduced its stake in Laboratory Corp. of America Holdings by 1.73% during the most recent quarter end. The investment management company now holds a total of 23,801 shares of Laboratory Corp. of America Holdings which is valued at $3,333,330 after selling 420 shares in Laboratory Corp. of America Holdings , the firm said in a disclosure report filed with the SEC on Aug 10, 2016.Laboratory Corp. of America Holdings makes up approximately 1.95% of Boston Research Management Inc’s portfolio.

Other Hedge Funds, Including , Pictet North America Advisors Sa reduced its stake in LH by selling 3,061 shares or 52.95% in the most recent quarter. The Hedge Fund company now holds 2,720 shares of LH which is valued at $380,936. Laboratory Corp. of America Holdings makes up approx 0.08% of Pictet North America Advisors Sa’s portfolio.Hartford Investment Management Co reduced its stake in LH by selling 18 shares or 0.07% in the most recent quarter. The Hedge Fund company now holds 24,564 shares of LH which is valued at $3,409,974. Laboratory Corp. of America Holdings makes up approx 0.07% of Hartford Investment Management Co’s portfolio.

Laboratory Corp. of America Holdings closed down -0.66 points or -0.48% at $138.05 with 4,94,938 shares getting traded on Friday. Post opening the session at $138.16, the shares hit an intraday low of $137.585 and an intraday high of $138.41 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Laboratory Corp. of America Holdings reported $2.31 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $2.30. The company had revenue of $2382.00 million for the quarter, compared to analysts expectations of $2334.01 million. The company’s revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.09 EPS.

Laboratory Corporation of America Holdings is an independent clinical laboratory company in the United States. Through a national network of laboratories the Company offers a range of clinical laboratory tests that are used by the medical profession in core testing patient diagnosis and in the monitoring and treatment of disease. The Company manages its operations through two segments: the Clinical diagnostics laboratory segment which includes core testing as well as genomic and esoteric testing; and the Other segment which consists of the Company’s non-United States clinical diagnostic laboratory operations in Ontario Canada. It also provides specialty testing services in the areas of allergy clinical trials diagnostic genetics women’s health cardiovascular disease identity forensics infectious disease endocrinology oncology coagulation occupational testing and pain management.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *